Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Usage of haloperidol for delirium in cancer patients.

Literature DB >> 8883234

Usage of haloperidol for delirium in cancer patients.

T Akechi¹, Y Uchitomi, H Okamura, M Fukue, A Kagaya, A Nishida, N Oomori, S Yamawaki.

Abstract

Although haloperidol is mainly used for the medical treatment of delirium in cancer patients, there are no universally accepted guidelines for its usage. We accordingly assessed the usefulness in managing delirium of a haloperidol treatment regimen in ten delirious cancer patients. The results of this preliminary study suggest that, in the management of delirium, appropriate usage of haloperidol on the first day is important as it affects the dosage thereafter.

Entities: Chemical Disease Species

Mesh：

Substances：
Haloperidol

Year: 1996 PMID： 8883234 DOI： 10.1007/bf01788847

Source DB: PubMed Journal: Support Care Cancer ISSN： 0941-4355 Impact factor: 3.603

7 in total

1. Acute confusional states in patients with advanced cancer.

Authors: F Stiefel; R Fainsinger; E Bruera
Journal: J Pain Symptom Manage Date: 1992-02 Impact factor: 3.612

2. A symptom rating scale for delirium.

Authors: P T Trzepacz; R W Baker; J Greenhouse
Journal: Psychiatry Res Date: 1988-01 Impact factor: 3.222

3. Emergency pharmacotherapy of delirium in the critically ill cancer patient.

Authors: F Adams; F Fernandez; B S Andersson
Journal: Psychosomatics Date: 1986-01 Impact factor: 2.386

4. Treatment of acute nonspecific delirium with i.v. haloperidol in surgical intensive care patients.

Authors: P Moulaert
Journal: Acta Anaesthesiol Belg Date: 1989

Review 5. Psychotropic medications in patients with cancer.

Authors: L G Peterson; M Leipman; B Bongar
Journal: Gen Hosp Psychiatry Date: 1987-09 Impact factor: 3.238

Review 6. Delirium in the older person with cancer.

Authors: S Weinrich; L Sarna
Journal: Cancer Date: 1994-10-01 Impact factor: 6.860

7. Delirium in terminally ill cancer patients.

Authors: M J Massie; J Holland; E Glass
Journal: Am J Psychiatry Date: 1983-08 Impact factor: 18.112

7 in total

Review 1. Delirium: where do we stand?

Authors: Chi-Un Pae; David M Marks; Changsu Han; Ashwin A Patkar; Prakash Masand
Journal: Curr Psychiatry Rep Date: 2008-06 Impact factor: 5.285

2. Delirium: is the confusion slowly clearing up.

Authors: F Stiefel
Journal: Support Care Cancer Date: 1996-09 Impact factor: 3.603

Review 3. Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development.

Authors: Shirley H Bush; Salmaan Kanji; José L Pereira; Daniel H J Davis; David C Currow; David Meagher; Kiran Rabheru; David Wright; Eduardo Bruera; Michael Hartwick; Pierre R Gagnon; Bruno Gagnon; William Breitbart; Laura Regnier; Peter G Lawlor
Journal: J Pain Symptom Manage Date: 2014-01-28 Impact factor: 3.612

7. A research study review of effectiveness of treatments for psychiatric conditions common to end-stage cancer patients: needs assessment for future research and an impassioned plea.

Authors: Ralph J Johnson
Journal: BMC Psychiatry Date: 2018-04-03 Impact factor: 3.630

7 in total

Usage of haloperidol for delirium in cancer patients.

1. Acute confusional states in patients with advanced cancer.

2. A symptom rating scale for delirium.

3. Emergency pharmacotherapy of delirium in the critically ill cancer patient.

4. Treatment of acute nonspecific delirium with i.v. haloperidol in surgical intensive care patients.

Review 5. Psychotropic medications in patients with cancer.

Review 6. Delirium in the older person with cancer.

7. Delirium in terminally ill cancer patients.

Review 1. Delirium: where do we stand?

2. Delirium: is the confusion slowly clearing up.

Review 3. Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development.

Review 4. Neuroleptics in the management of delirium in patients with advanced cancer.

5. Delirium: underrecognized and undertreated.

6. Comparison of efficacy of haloperidol and olanzapine in the treatment of delirium.

7. A research study review of effectiveness of treatments for psychiatric conditions common to end-stage cancer patients: needs assessment for future research and an impassioned plea.